NCT05658354

Brief Summary

The goal of this clinical trial is to investigate the possibility of rehabilitation of mild cognitive deficits in people with metabolic syndrome. We aim to implement a cognitive training program on patients with metabolic syndrome and cognitive deficits, and examine its effectiveness both post-intervention (3 months) and after 12 months. Researchers will compare two groups, the experimental group that will receive the computerized cognitive training and the control group that will receive no training.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2022

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

December 8, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 20, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2025

Completed
Last Updated

July 2, 2025

Status Verified

June 1, 2025

Enrollment Period

2.3 years

First QC Date

December 8, 2022

Last Update Submit

June 28, 2025

Conditions

Keywords

metabolic syndromemild cognitive deficitscomputerized cognitive rehabilitation

Outcome Measures

Primary Outcomes (9)

  • Change in scores of the Montreal Cognitive Assessment (MoCA) test

    MoCA is a screening test for mild cognitive dysfunction; range 0-30, higher scores represent better cognitive function

    baseline, post-intervention (3 months), follow-up (1 year from baseline)

  • Change in scores of Complex Figure tests

    Complex Figures assess visuo-constructional ability and visual memory; range 0-36, higher scores represent better cognitive function

    baseline, post-intervention (3 months), follow-up (1 year from baseline)

  • Change in scores of Hopkins Verbal Learning Test-Revised (HVLT-R)

    HVLT-R assesses verbal memory using a list of words; range 0-36 (immediate recall) and range 0-12 (delayed recall), higher scores represent better cognitive function

    baseline, post-intervention (3 months), follow-up (1 year from baseline)

  • Change in scores of Digit Span test

    Digit Span assesses working memory; range 0-14 (performance) and range 2-9 (span) for forward and backward condition, higher scores represent better cognitive function

    baseline, post-intervention (3 months), follow-up (1 year from baseline)

  • Change in scores of semantic Verbal Fluency test

    Verbal Fluency assesses executive function that also relies on language component; higher scores represent better cognitive function

    baseline, post-intervention (3 months), follow-up (1 year from baseline)

  • Change in scores of Flanker task

    Flanker task assesses executive function and inhibition; range 0-48, higher scores represent better cognitive function

    baseline, post-intervention (3 months), follow-up (1 year from baseline)

  • Change in scores of Continuous Performance Test (CPT)

    CPT assesses executive function and inhibition; range 0-100, higher scores represent better cognitive function

    baseline, post-intervention (3 months), follow-up (1 year from baseline)

  • Change in scores of Set Shifting

    Set Shifting assesses executive function and set-shifting; range 0-104, higher scores represent better cognitive function

    baseline, post-intervention (3 months), follow-up (1 year from baseline)

  • Change in scores of N-back

    N-back assesses working memory; range 0-30, higher scores represent better cognitive function

    baseline, post-intervention (3 months), follow-up (1 year from baseline)

Secondary Outcomes (1)

  • Change in scores of Everyday Cognition-II (Ecog-II)

    baseline, follow-up (1 year from baseline)

Study Arms (2)

Computerized cognitive program

EXPERIMENTAL

25 participants with metabolic syndrome and mild cognitive deficits; receive health advice using the World Health Organization's guidelines for Risk Reduction of Cognitive Decline and Dementia, and perform the computerized cognitive training program (BrainHQ) for 45 minutes per session, twice per week, over the 3-month intervention period.

Other: Computerized cognitive program

Control group

NO INTERVENTION

25 participants with metabolic syndrome and mild cognitive deficits; receive health advice using the World Health Organization's guidelines for Risk Reduction of Cognitive Decline and Dementia.

Interventions

BrainHQ was developed by Posit Science and includes computer-based brain-training exercises organized into six categories: Attention, Brain Speed, Memory, People Skills, Intelligence, and Navigation. Participants were instructed to perform a total of 24 sessions of computerized cognitive training at home, consisting of 45 minutes of training, twice per week, over a 3-month period.

Computerized cognitive program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Presence of metabolic syndrome according to the criteria of IDF (2005) or revised NCEP-ATP III (2005)
  • Presence of mild cognitive deficit (-1.5 SD below age and education-adjusted normative mean) in previously administered neuropsychological tests of Trail Making test (Part A \& B), Verbal Fluency test (animals and letter "x"), Logical Memory test (immediate and delayed recall)
  • Written informed consent to participate

You may not qualify if:

  • Presence of any serious neurological or psychiatric condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina

Ioannina, 45110, Greece

Location

MeSH Terms

Conditions

Metabolic SyndromeCognition Disorders

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD candidate

Study Record Dates

First Submitted

December 8, 2022

First Posted

December 20, 2022

Study Start

December 1, 2022

Primary Completion

March 20, 2025

Study Completion

March 20, 2025

Last Updated

July 2, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations